{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T11:29:43Z","timestamp":1778498983596,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1136\/ijgc-2023-004592","type":"journal-article","created":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T07:10:26Z","timestamp":1692429026000},"page":"1890-1897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Predicting resectable disease in relapsed epithelial ovarian cancer by using whole-body diffusion-weighted MRI"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5660-1591","authenticated-orcid":false,"given":"Sander","family":"Dumont","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0800-3279","authenticated-orcid":false,"given":"Vincent","family":"Vandecaveye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6593-4582","authenticated-orcid":false,"given":"Rapha\u00ebla Carmen","family":"Dresen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5432-1828","authenticated-orcid":false,"given":"Els","family":"Van Nieuwenhuysen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7207-1519","authenticated-orcid":false,"given":"Tha\u00efs","family":"Baert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5452-4905","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Amant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7331-3660","authenticated-orcid":false,"given":"Val\u00e9rie","family":"Broeckhoven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2564-721X","authenticated-orcid":false,"given":"Toon","family":"Van Gorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2023-004592_bb0010","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1056\/NEJMoa2103294","article-title":"Randomized trial of cytoreductive surgery for relapsed ovarian cancer","volume":"385","author":"Harter","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2023-004592_bb0015","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1470-2045(21)00006-1","article-title":"Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial","volume":"22","author":"Shi","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2023-004592_bb0020","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/ijgc-2019-000308","article-title":"ESMO\u2013ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease","volume":"29","author":"Colombo","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-004592_bb0025","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1200\/JCO.21.02085","article-title":"Secondary cytoreductive surgery in platinum-sensitive recurrent ovarian cancer: a meta-analysis","volume":"40","author":"Baek","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2023-004592_bb0030","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2023.34.e31","article-title":"The value of PET\/CT for cytoreductive surgery selection in recurrent ovarian carcinoma","volume":"34","author":"Nunes","year":"2023","journal-title":"J Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004592_bb0035","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/uog.23654","article-title":"Preoperative staging of ovarian cancer: comparison between ultrasound, CT and whole-body diffusion-weighted MRI (ISAAC study)","volume":"59","author":"Fischerova","year":"2022","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1136\/ijgc-2023-004592_bb0040","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000159266","article-title":"A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PET\/CT and staging laparoscopy","volume":"75","author":"Fagotti","year":"2008","journal-title":"Oncology"},{"key":"10.1136\/ijgc-2023-004592_bb0045","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20160468","article-title":"Whole-body diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent ovarian cancer: a clinical feasibility study","volume":"89","author":"Michielsen","year":"2016","journal-title":"Br J Radiol"},{"key":"10.1136\/ijgc-2023-004592_bb0050","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1245\/s10434-011-1873-2","article-title":"A risk model for secondary cytoreductive surgery in recurrent ovarian cancer: an evidence-based proposal for patient selection","volume":"19","author":"Tian","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1136\/ijgc-2023-004592_bb0055","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ygyno.2015.02.004","article-title":"External validation of two prediction models of complete secondary cytoreductive surgery in patients with recurrent epithelial ovarian cancer","volume":"137","author":"van de Laar","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004592_bb0060","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejca.2017.06.010","article-title":"Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer","volume":"83","author":"Michielsen","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2023-004592_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"FIGO Committee on Gynecologic Oncology","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2023-004592_bb0070","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"10.1136\/ijgc-2023-004592_bb0075","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ygyno.2012.09.013","article-title":"Neoadjuvant chemotherapy in advanced ovarian cancer: on what do we agree and disagree?","volume":"128","author":"Vergote","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004592_bb0080","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1097\/IGC.0000000000001041","article-title":"European Society of Gynaecological Oncology (ESGO) guidelines for ovarian cancer surgery","volume":"27","author":"Querleu","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-004592_bb0085","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/IGC.0000000000001219","article-title":"Positive DESKTOP and Tian scores systems are adequate to predict optimal (R0) secondary debulking surgery in ovarian cancer, but a negative score does not preclude secondary surgery","volume":"28","author":"Laga","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-004592_bb0090","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.diii.2022.05.003","article-title":"The BUMPy road of peritoneal metastases in ovarian cancer","volume":"103","author":"Nougaret","year":"2022","journal-title":"Diagn Interv Imaging"},{"key":"10.1136\/ijgc-2023-004592_bb0095","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2023-004592_bb0100","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00330-019-06469-1","article-title":"MRI versus 18F-FDG-PET\/CT for detecting bone marrow involvement in multiple myeloma: diagnostic performance and clinical relevance","volume":"30","author":"Lecouvet","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1136\/ijgc-2023-004592_bb0105","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ajog.2008.06.052","article-title":"Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma","volume":"199","author":"Fagotti","year":"2008","journal-title":"Am J Obstet Gynecol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24014634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24014634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2023-004592","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:28:04Z","timestamp":1753234084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24014634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1048891X24014634"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2023-004592","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting resectable disease in relapsed epithelial ovarian cancer by using whole-body diffusion-weighted MRI","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2023-004592","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}